Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             57 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 An Appraisal of Good Regulatory Review Practices in the Gulf Cooperation Council States Al-Essa, Reem
 2012
 46 1 p. 57-64
 artikel
2 An Appraisal of Good Regulatory Review Practices in the Gulf Cooperation Council States Al-Essa, Reem
 2012
 46 1 p. 57-64
 artikel
3 An Appraisal of Good Regulatory Review Practices in the Gulf Cooperation Council States Al-Essa, Reem
46 1 p. 57-64
 artikel
4 An In-Process Scaling Model Smith, Alan
 2012
 46 1 p. 8-12
 artikel
5 An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement Smith, Alan
 2012
 46 1 p. 8-12
 artikel
6 An In-Process Scaling Model: A Potential Framework for Data Monitoring Committees and Clinical Trial Quality Improvement Smith, Alan
46 1 p. 8-12
 artikel
7 Cobert’s Manual of Drug Safety and Pharmacovigilance Tabor, Edward
46 1 p. 140
 artikel
8 Cobert’s Manual of Drug Safety and Pharmacovigilance (2nd ed) Tabor, Edward
 2012
 46 1 p. 140
 artikel
9 Cobert’s Manual of Drug Safety and Pharmacovigilance (2nd ed) Tabor, Edward
 2012
 46 1 p. 140-140
 artikel
10 CPI™ Certification as Predictor of Clinical Investigators’ Regulatory Compliance Vulcano, David M.
46 1 p. 84-87
 artikel
11 CPItm Certification as Predictor of Clinical Investigators’ Regulatory Compliance Vulcano, David M.
 2012
 46 1 p. 84-87
 artikel
12 CPItm Certification as Predictor of Clinical Investigators’ Regulatory Compliance Vulcano, David M.
 2012
 46 1 p. 84-87
 artikel
13 Development and Application of Scorecards to Assess the Quality of a Regulatory Submission and Its Review Salek, Sam
 2012
 46 1 p. 73-83
 artikel
14 Development and Application of Scorecards to Assess the Quality of a Regulatory Submission and Its Review Salek, Sam
 2012
 46 1 p. 73-83
 artikel
15 Development and Application of Scorecards to Assess the Quality of a Regulatory Submission and Its Review Salek, Sam
46 1 p. 73-83
 artikel
16 Editor-in-Chief’s Commentary Turner, J. Rick
 2012
 46 1 p. 5-6
 artikel
17 Editor-in-Chief’s Commentary: SAGE Publishes the Drug Information Journal Turner, J. Rick
 2012
 46 1 p. 5-6
 artikel
18 Editor-in-Chief’s Commentary: SAGE Publishes the Drug Information Journal Turner, J. Rick
46 1 p. 5-6
 artikel
19 Experiences With the Approval of Clinical Trials in Germany Ruppert, Thorsten
 2012
 46 1 p. 43-56
 artikel
20 Experiences With the Approval of Clinical Trials in Germany: Results of a Survey of Research-Based Pharmaceutical Companies Ruppert, Thorsten
 2012
 46 1 p. 43-56
 artikel
21 Experiences With the Approval of Clinical Trials in Germany: Results of a Survey of Research-Based Pharmaceutical Companies Ruppert, Thorsten
46 1 p. 43-56
 artikel
22 Exposure to and Understanding of Technical Terms in Informed Consent Forms for Biomedical Research Jeong, Ihn Sook
 2012
 46 1 p. 19-26
 artikel
23 Exposure to and Understanding of Technical Terms in Informed Consent Forms for Biomedical Research Jeong, Ihn Sook
 2012
 46 1 p. 19-26
 artikel
24 Exposure to and Understanding of Technical Terms in Informed Consent Forms for Biomedical Research Jeong, Ihn Sook
46 1 p. 19-26
 artikel
25 Flexible Phase I Study Designs Underwood, David
 2012
 46 1 p. 13-18
 artikel
26 Flexible Phase I Study Designs: Expediting Early Clinical Drug Development Underwood, David
 2012
 46 1 p. 13-18
 artikel
27 Flexible Phase I Study Designs: Expediting Early Clinical Drug Development Underwood, David
46 1 p. 13-18
 artikel
28 Improving Time to Pharmaceutical Approval Masciale, Andrea C.
 2012
 46 1 p. 35-42
 artikel
29 Improving Time to Pharmaceutical Approval: An Analysis of the Prescription Drug User Fee Act Process Masciale, Andrea C.
 2012
 46 1 p. 35-42
 artikel
30 Improving Time to Pharmaceutical Approval: An Analysis of the Prescription Drug User Fee Act Process Masciale, Andrea C.
46 1 p. 35-42
 artikel
31 Patient Nonadherence in Clinical Trials Smith, Dorothy L.
 2012
 46 1 p. 27-34
 artikel
32 Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety? Smith, Dorothy L.
 2012
 46 1 p. 27-34
 artikel
33 Patient Nonadherence in Clinical Trials: Could There Be a Link to Postmarketing Patient Safety? Smith, Dorothy L.
46 1 p. 27-34
 artikel
34 Providing Medical Information for Orphan Drugs Turbeville, Sean
 2012
 46 1 p. 88-93
 artikel
35 Providing Medical Information for Orphan Drugs Turbeville, Sean
 2012
 46 1 p. 88-93
 artikel
36 Providing Medical Information for Orphan Drugs Turbeville, Sean
46 1 p. 88-93
 artikel
37 Regulatory Review Process in the Gulf Cooperation Council States Al-Essa, Reem
 2012
 46 1 p. 65-72
 artikel
38 Regulatory Review Process in the Gulf Cooperation Council States: Similarities and Differences Al-Essa, Reem
 2012
 46 1 p. 65-72
 artikel
39 Regulatory Review Process in the Gulf Cooperation Council States: Similarities and Differences Al-Essa, Reem
46 1 p. 65-72
 artikel
40 Text Analytics for Surveillance (TAS) Christensson, Camilla
 2012
 46 1 p. 115-123
 artikel
41 Text Analytics for Surveillance (TAS): An Interactive Environment for Safety Literature Review Christensson, Camilla
 2012
 46 1 p. 115-123
 artikel
42 Text Analytics for Surveillance (TAS): An Interactive Environment for Safety Literature Review Christensson, Camilla
46 1 p. 115-123
 artikel
43 The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide Schumock, Glen T.
 2012
 46 1 p. 99-106
 artikel
44 The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide Schumock, Glen T.
 2012
 46 1 p. 99-106
 artikel
45 The Association Between Leukotriene-Modifying Agents and Spontaneously Reported Suicide Schumock, Glen T.
46 1 p. 99-106
 artikel
46 The Correction of Product Information in Drug References and Medical Textbooks Lum, Ching
 2012
 46 1 p. 94-98
 artikel
47 The Correction of Product Information in Drug References and Medical Textbooks Lum, Ching
 2012
 46 1 p. 94-98
 artikel
48 The Correction of Product Information in Drug References and Medical Textbooks PharmD, Ching Lum
46 1 p. 94-98
 artikel
49 The Ditchley Transparency Manifesto Lofstedt, Ragnar
 2012
 46 1 p. 7
 artikel
50 The Ditchley Transparency Manifesto Lofstedt, Ragnar
 2012
 46 1 p. 7-7
 artikel
51 The Ditchley Transparency Manifesto Lofstedt, Ragnar
46 1 p. 7
 artikel
52 The Electronic Common Technical Document (eCTD) Suchanek, Andreas
 2012
 46 1 p. 124-139
 artikel
53 The Electronic Common Technical Document (eCTD): An International Pro/Con Analysis of the Pharmaceutical Product Electronic Submission Process Suchanek, Andreas
 2012
 46 1 p. 124-139
 artikel
54 The Electronic Common Technical Document (eCTD): An International Pro/Con Analysis of the Pharmaceutical Product Electronic Submission Process Suchanek, Andreas
46 1 p. 124-139
 artikel
55 The Role of Pharmaceutical Medical Information in Promotional Review Bonk, Lisa
 2012
 46 1 p. 107-114
 artikel
56 The Role of Pharmaceutical Medical Information in Promotional Review: Three Benchmarking Surveys Bonk, Lisa
 2012
 46 1 p. 107-114
 artikel
57 The Role of Pharmaceutical Medical Information in Promotional Review: Three Benchmarking Surveys Bonk, Lisa
46 1 p. 107-114
 artikel
                             57 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland